Beate Stern
Fondatore presso Uni Targeting Research AS
Posizioni attive di Beate Stern
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | - |
| Fondatore | 28/07/2009 | - | |
| University of Bergen | Corporate Officer/Principal | - | - |
Storia della carriera di Beate Stern
Precedenti posizioni note di Beate Stern
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Norvegia | 3 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Health Technology |
- Borsa valori
- Insiders
- Beate Stern
- Esperienza
